AstraZeneca PLC (STO:AZN)
Sweden · Delayed Price · Currency is SEK 1,703.50
+1.00 (0.06%)
At close: Dec 30, 2025
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 2.65 trillion as of December 31, 2025. Its market cap has increased by 18.70% in one year.
Market Cap
2.65T
Enterprise Value
2.88T
Revenue
547.72B
Ranking
n/a
PE Ratio
29.95
Stock Price
1,703.50
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 50.94B to 2.65T, an increase of 5,107.59%. That is a compound annual growth rate of 12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.65T | 17.77% |
| Dec 31, 2024 | 2.25T | 6.54% |
| Dec 29, 2023 | 2.11T | -3.33% |
| Dec 30, 2022 | 2.18T | 32.64% |
| Dec 31, 2021 | 1.65T | 52.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.70B |
| Getinge AB | 59.59B |
| Sectra AB | 48.36B |
| Camurus AB | 36.74B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.33B |
| BioArctic AB | 27.55B |
| Elekta AB | 21.68B |